Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: Studies in an ex vivo perfusion chamber model

British Journal of Haematology

Volumn 119, Issue 4, 2002, Pages 998-1004

  Hainaud, Patricia ^a   Brouland, Jean Philippe ^a   André, Patrick ^a   Simoneau, Guy ^a   Sollier, Claire Bal Dit ^a   Drouet, Ludovic ^a   Caen, Jacques ^a   Bellucci, Sylvia ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

IIb 3 integrin; Fibrin; Glanzmann's thrombasthenia; Perfusion chamber; Thrombi

Indexed keywords

COLLAGEN TYPE 3; FIBRIN; FIBRINOGEN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISSOCIATION; FEMALE; GLANZMANN DISEASE; HEMOSTASIS; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MODEL; PERFUSION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ADHESION; THROMBOGENESIS;

BLOOD PLATELETS; COLLAGEN TYPE III; DIFFUSION CHAMBERS, CULTURE; FEMALE; FIBRIN; FIBRINOGEN; HETEROZYGOTE; HUMANS; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBASTHENIA; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 18744407550     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03966.x     Document Type: Article

References (58)

1. André, P., Arbeille, B., Drouet, V., Hainaud, P., Bal dit Sollier, C., Caen, J.-P. & Drouet, L.-O. (1996) Optimal antagonism of GPIIb/ IIIa favors platelet adhesion by inhibiting thrombus growth: An ex-vivo capillary perfusion chamber study in the guinea pig. Arteriosclerosis Thrombosis and Vascular Biology, 16, 56-63.
2. Barnes, M.-J., Knight, C.-G. & Farndale, R.-W. (1998) The collagen-platelet interaction. Current Opinion in Hematology, 5, 314-320.
3. Barstad, R.-M., Orvim, U., Hamers, M.-J., Tjonnfjord, G.-E., Bross-tad, F.-R. & Sakariassen, K.-S. (1996) Reduced effect of aspirin on thrombus formation at high shear rates and disturbed laminar blood flow. Thrombosis and Haemostasis, 75, 827-832.
4. Baumgartner, H.-R. (1973) The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvascular Research, 5, 167-179.
5. Baumgartner, H.-R., Tschopp, T.-B. & Weiss, H.-J. (1977) Platelet interaction with collagen fibrils in flowing blood. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium. Thrombosis and Haemostasis, 37, 17-28.
6. Beguin, S., Kumar, R., Keularts, I., Seligsohn, U., Coller, B.-S. & Hemker, H.-C. (1999) Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood, 93, 564-570.
7. Bellucci, S. & Caen, J. (2002) Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment. Blood Reviews (in press).
8. Caen, J.-P. (1989) Glanzmann's thrombasthenia. Baillieres' Clinical Haematology, 2, 609-625.
9. Caen, J.-P. & Rosa, J.-P. (1995) Platelet-vessel wall interaction: From the bedside to molecules. Thrombosis and Haemostasis, 74, 18-24.
10. Caen, J.-P., Castaldi, P.-A., Leclerc, J.-C., Inceman, S., Larrieu, M.-J., Probst, M. & Bernard, J. (1966) Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann's thrombasthenia (report of 15 patients). American Journal of Medicine, 41, 4-26.
11. Caen, J.-P., Rosa, J.-P., Soria, C. & Boizard, B. (1983) Variant de thrombasthénie Paris-I Lariboisière, anomalie mole ́culaire du complexe glycoprote ́inique plaquettaire IIb-IIIa. Comptes-Rendus de l'Académie des Sciences, 296, 479-481.
12. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proceedings of National Academy of Sciences of the United States of America, 89, 10169-10173.
13. 3 (platelet glycoprotein IIb-IIIa). Blood, 84, 1857-1865.
14. 3 Arg 214 by Trp. Human Molecular Genetics, 2, 2179-2180.
15. 3 gene associated with Glanzmann's thrombasthenia. Human Molecular Genetics, 2, 2183-2185.
16. Fox, J.E. (2001) Cytoskeletal proteins and platelet signaling. Thrombosis and Haemostasis, 86, 198-213.
17. Fullard, J., Murphy, R., O'Neill, S., Moran, N., Cottridge, B. & Fitzerald, D.J. (2001) A Val193Met mutation in GPIIIa results in a GPIIb/IIIa receptor with a constitutively high affinity for a small ligand. British Journal of Haematology, 115, 131-139.
18. George, J.-N., Caen, J.-P. & Nurden, A.-T. (1990) Glanzmann's Thrombasthenia: The spectrum of clinical disease. Blood, 75, 1383-1395.
19. Ginsberg, M.-H., Lightsey, A., Kunicki, T.-J., Kaufman, A., Marguerie, G. & Plow, E.-F. (1986) Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. Journal of Clinical Investigation, 78, 1103-1111.
20. Grimaldi, C.M., Chen, F., Scudder, L.E., Coller, B.S. & French, D.L. (1996) A Cys374Tyr homozygous mutation of platelet glyco-protein IIIa (β3) in a Chinese patient with Glanzmann's thrombasthenia. Blood, 88, 1666-1675.
21. Grimaldi, C.M., Chen, F., Wu, C., Weiss, H.J., Coller, B.S. & French, D.L. (1998) Glycoprotein IIb Leu 214Pro mutation produces Glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa. Blood, 91, 1562-1571.
22. Gruel, Y., Boizard, B., Daffos, F., Forestier, F., Caen, J. & Wautier, J.-L. (1986) Determination of platelet antigens and glycoproteins in the human fetus. Blood, 68, 488-492.
23. Gruel, Y., Pacouret, G., Bellucci, S. & Caen, J.-P. (1997) Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin. Blood, 90, 888-890.
24. Hynes, R.-O. (1992) Integrins: Versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25.
25. 3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia. Thrombosis and Haemostasis, 80, 42-48.
26. 3 integrin in mediating fibrin gel retraction. Journal of Biological Chemistry, 270, 1785-1790.
27. Kirchhofer, D., Tschopp, T.B., Steiner, B. & Baumgartner, H.-R. (1995) Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood, 86, 3815-3822.
28. 214Trp mutation. Journal of Clinical Investigation, 89, 1995-2004.
29. Lawrence, J.-B. & Gralnick, H.-R. (1987) Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: Effects on platelet spreading and ultrastructure on human arterial subendothelium. Journal of Laboratory and Clinical Medicine, 109, 495-503.
30. Le Charpentier, Y., Galian, A., Gaste, A. & Herbe, L. (1981) L'etude en immunofluorescence des biopsies jejunales (incluses en resine epoxy) au cours de la maladie des chaines alpha. Annales de Pathologie, 1, 160-162.
31. Lee, H., Nurden, A.-T., Thomaidis, A. & Caen, J.-P. (1981) Relationship between fibrinogen binding and the platelet glyco-protein deficiencies in Glanzmann's thrombasthenia type I and II. British Journal of Haematology, 48, 47-57.
32. Loscalzo, J., Inbal, A. & Handin, R.I. (1986) Von Willebrand protein facilitates platelet incorporation into polymerizing fibrin. Journal of Clinical Investigation, 78, 1112-1119.
33. Morel-Kopp, M.C., Melchior, C., Chen, P., Ammerlaan, W., Lecompte, T., Kaplan, C. & Kieffer, N. (2001) A naturally occuring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function. Thrombosis and Haemostasis, 86, 1425-1434.
34. Nachman, R.-L. & Leung, L.-L. (1982) Complex formation of platelet membrane glycoprotein IIbIIIa with fibrinogen. Journal of Clinical Investigation, 69, 263-269.
35. Newman, P.-J., Seligsohn, U., Lyman, S. & Coller, B.-S. (1991) The molecular genetic basis of Glanzmannn thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proceedings of National Academy of Sciences of the United States of America, 88, 3160-3164.
36. Niewiarowski, S., Levy-toledano, S. & Caen, J.-P. (1981) Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia. Thrombosis Research, 23, 457-463.
37. Nurden, A.T. (1999) Inherited abnormalities of platelets. Thrombosis and Haemostasis, 82, 468-480.
38. Nurden, A.-T. & Caen, J.-P. (1974) An abnormal glycoprotein pattern in three cases of Glanzmann' thrombasthenia. British Journal of Haematology, 28, 253-260.
39. Nurden, A.-T. & Caen, J.-P. (1975) Specific roles for platelet surface glycoproteins in platelet function. Nature, 255, 720-722.
40. Nurden, A.-T., Rosa, J.-P., Fournier, D., Legrand, C., Didry, D., Parquet, A. & Pidard, D. (1987) A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane. Journal of Clinical Investigation, 79, 962-969.
41. Nurden, A.-T., Poujol, C., Durrieu-Jais, C. & Nurden, P. (1999) Platelet glycoprotein IIb/IIIa inhibitors: Basic and clinical aspects. Arteriosclerosis Thrombosis and Vascular Biology, 19, 2835-2840.
42. Reverter, J.-C., Be ́guin, S., Kessels, H., Kumar, R., Hemker, H.-C. & Coller, B.-S. (1996) Inhibition of Platelet-mediated, tissue factor induced thrombin generation by the mouse/human chimeric 7E3 antibody. Journal of Clinical Investigation, 98, 863-874.
43. Rooney, M.M., Parise, L.V. & Lord, S.T. (1996) Dissecting clot retraction and platelet aggregation. Journal of Biological Chemistry, 271, 8553-8555.
44. Ruggeri, Z.-M. (1997) Mechanisms initiating platelet thrombus formation. Thrombosis and Haemostasis, 78, 611-616.
45. 3) integrin locked in a high-affinity state and a Glanzmann) thrombasthenia-like phenotype. Blood, 98, 2432-2441.
46. Sakariassen, K.-S., Nievelstein, P.-F.-E.-M., Coller, B.-S. & Sixma, J.-J. (1986) The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. British Journal of Haematology, 63, 681-691.
47. Sakariassen, K.-S., Fressinaud, E., Girma, J.-P., Meyer, D. & Baumgartner, H.-R. (1987) Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to sub-endothelium and collagen. Annals of the New York Academy of Sciences, 516, 52-65.
48. Sakariassen, K.-S., Kuhn, H., Muggli, R. & Baumgartner, H.-R. (1988) Growth and stability of thrombi in flowing citrated blood: Assessment of platelet-surface interactions with computer-assisted morphometry. Thrombosis and Haemostasis, 60, 392-398.
49. Schlegel, N., Chen, P., Binard, S., Maisonneuve, L., Rosa, J.-P., Kieffer, N. & Caen, J.-P. (1999) Type II Glanzmann thrombasthenia (GT) in a compound heterozygote for the glycoprotein (GP) IIIa gene associating two novel mutations, a stop codon (Arg 216) and a Cys598Tyr substitution in mature GPIIIa. Blood, 94, 451a.
50. Shattil, S.-J., Kashiwagi, H. & Pampori, N. (1998) Integrin signaling: The platelet paradigm. Blood, 91, 2645-2657.
51. 3 integrins. Thrombosis and Haemostasis, s250, 784a.
52. Tschopp, T.-B., Weiss, H.-J. & Baumgartner, H.-R. (1975) Interaction of thrombasthenic platelets with subendothelium: Normal adhesion, absent aggregation. Experientia, 31, 113-116.
53. Ward, C.-M., Kestin, A.-S. & Newman, P.-J. (2000) A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen. Blood, 96, 161-169.
54. Weiss, H.-J., Turitto, V.-T. & Baumgartner, H.-R. (1986) Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood, 67, 322-330.
55. Weiss, H.-J., Baumgartner, H.-R. & Turitto, V.-T. (1987) Regulation of platelet-fibrin thrombi on subendothelium. Annals of the New York Academy of Sciences, 516, 380-397.
56. Weiss, H.-J., Turitto, V.-T. & Baumgartner, H.-R. (1991) Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thrombosis and Haemostasis, 65, 202-205.
57. 1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium. Journal of Laboratory Clinical Medicine, 122, 324-332.
58. Wilcox, D.A., Paddock, C.M., Lyman, S., Gill, J.C. & Newman, P.J. (1995) Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domain of GPIIb. Journal of Clinical Investigation, 95, 1553-1560.